Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Clinical News

RG-101: Interim Phase II data

February 22, 2016 8:00 AM UTC

Interim data from 38 treatment-naive patients with chronic HCV genotype 1 or 4 infection in a Phase II trial showed that a single subcutaneous injection of 2 mg/kg RG-101 followed by an approved once-...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article